fermentek makes and sells biochemicals for research
 
Fermentek products delivered worldwide by courier
Fermentek homepage
about
support, sale policy, gmo, mad cow safety, privacy products
contact us
cancer research reagents

Fumonisin B2

MSDSSample CoA
 
Source: Fusarium moniliforme
Synonyms 
Description: Structural analog of Fumonisin B1.  Fumonisin B2 is more cytotoxic than Fumonisin B1. Fumonisin B2 inhibits  sphingosine acyl-transterase.
CAS number: 116355-84-1
Merck index: 13:4310 (Fumonisin)
Molecular weight: 705.8
Structure:

 

Molecular Formula: C34H59NO14
Canonical SMILES: CCCCC(C)C(C(CC(C)CCCCCCC(CC(C(C)N)O)O)OC(=O)CC(CC(=O)O)C(=O)O)OC(=O)CC(CC(=O)O)C(=O)O
Solubility
information:
Methanol
Specifications 
Appearance: Off-white solid.
PurityNot less than 96% by TLC. At least 98% by HPLC
λmax: 
Melting point 
Solubility 
Storage+4C. Protect from light.
Applications 
WarningsCarcinogen
Classificationisoflavonoid
Phytoestrogen.
sphingosine acyl-transterase inhibitor
Related products
   Fumonisin B2  

  Zearalenone   Fumonisin_B1    DON     3-acetyl-DON

  For Research use only. Not for Human or Drug use
GMP/API grade available on request
Fumonisin B2 by Fermentek is not produced from or contains any ingredients from animal origin.
No genetically modified organisms are used.
Publications Turner PC, Nikiema P, Wild CP.
Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.
Mutat Res. 1999 Jul 15;443(1-2):81-93. Review.
  Bucci TJ, Howard PC, Tolleson WH, Laborde JB, Hansen DK.
Renal effects of fumonisin mycotoxins in animals.
Toxicol Pathol. 1998 Jan-Feb;26(1):160-4. Review
  Shephard GS.
Chromatographic determination of the fumonisin mycotoxins.
J Chromatogr A. 1998 Jul 31;815(1):31-9. Review.
  Desai K, Sullards MC, Allegood J, Wang E, Schmelz EM, Hartl M, Humpf HU, Liotta DC, Peng Q, Merrill AH Jr.
Fumonisins and fumonisin analogs as inhibitors of ceramide synthase and inducers of apoptosis.
Biochim Biophys Acta. 2002 Dec 30;1585(2-3):188-92
  Duvick J.
Prospects for reducing fumonisin contamination of maize through genetic modification.
Environ Health Perspect. 2001 May;109 Suppl 2:337-42. Review.
  Miller JD.
Factors that affect the occurrence of fumonisin.
Environ Health Perspect. 2001 May;109 Suppl 2:321-4. Review.
AVAILABLE
Standard solutions

 Fumonisin B2 solution


 Fumo. B1,B2 mix


fermentek 

Sitemap

Home Hebrew About  us ISO GMP/API Products Mad cow Sales policy Receiving RFQ Ask scientistContact salesPrivacy  About website 

Products

7AAD17AAG17DMAGA23187 ActinomycinAflatoxin B1Aflatoxin B2Aflatoxin M1AlamethicinAnisomycinApicidinAphidicolinAscomycin
Bafilomycin Brefeldin CastanospermineCeruleninChelerythrineChromomycin A3CitreoviridinCitrininCyclopamineCytochalasin ACytochalasin B
Cytochalasin CCytochalasin DCytochalasin EDihidrocytochalasinDeoxynivalenolDiacetoxyscirpenolFK506ForskolinFumagillinFumonisinGeldanamycin
GliotoxinHypericinHT2 toxinIonomycinK252AK252CKT5720KT5823Leptomycin BMithramycin AMoniliforminMycophenolicMyriocinNigericin
NonactinOchratoxin AOligomycinParthenolidePatulinPaxillinePenicillic acidPenitremPKC412PuromycinPuromycin ANRadicicolStaurosporine
SterigmatocystinT2 toxinTentnoxinThapsigarginThiolutinThiostreptonTriacsinTrichostatinTunicamycinValinomycinVerruculogenVomitoxin
Withaferin WortmanninZearalenone

statcounter 

unique visitor counter
 
Company's eMail: 

Anti-spam measures have been taken here. Please copy this address into your eMail software. We are sorry for the inconvenience.

Mail Address:
Yatziv 25, Atarot industrial zone,
POB 47120, Jerusalem 97800 Israel
Fax:     972 2 5853943
Phone: 972 2 5853953